Shockwave Medical

Discover waves of learning opportunities at our #EuroPCR 2026 Shockwave Training Village! ​ Whether you're interested in #ShockwaveC2Aero, imaging optimization, the CALC checklist or #ShockwaveReducer, we have something planned for you. Flip through this 15-session lineup to start planning your congress, then add your favorite sessions to your calendar today: #village" target="_blank" rel="nofollow noopener">shockwavemedical.com/europcr-2026/?…  ​ IVL US Rx only. Reducer Investigational Use Only (US & CAN).​ Safety Information: shockwavemedical.com/isi/  Product availability may vary by country.

From innovation to true impact ⚡ Dr Benjamin Honton (@HontonB) shares his experience performing the first #ShockwaveC2Aero cases in Europe. ​ Hear what he thinks of the new features, from the better profile to improved re-wrap capabilities compared to Shockwave C2+, and what it means for his practice. ​ A new chapter in coronary calcium treatment has now begun in Europe. Learn more: shockwavemedical.com/en-eu/products…  ​ US Rx only. Safety Info: shockwavemedical.com/isi/ Product availability may vary by country.

Physicians asked for more #CoronaryIVL capabilities — and we delivered. #ShockwaveC2Aero's design upgrades allow clinicians to tackle all types of complex coronary calcium with even greater confidence. In today's press release, Dr Margaret McEntegart (@mbmcentegart) shared, “By continuing to address real unmet physician needs like deliverability, crossability and repositioning, Johnson & Johnson is pushing expectations for what the technology can achieve in complex PCI procedures.” Read the Press Release: shockwavemedical.com/news/johnson-j… Learn more about #ShockwaveC2Aero: shockwavemedical.com/products/shock… US Rx only. Safety Info: shockwavemedical.com/isi/  Product availability may vary by country.

We are proud to announce the global launch of our next-generation #ShockwaveIVL catheter, Shockwave C2 Aero. Addressing unmet needs in deliverability, lesion crossing, and balloon repositioning, it's here to reset physicians’ expectations for #CoronaryIVL. Read the Press Release: shockwavemedical.com/news/johnson-j…  Learn more about #ShockwaveC2Aero: shockwavemedical.com/products/shock…  US Rx only. Safety Info:  shockwavemedical.com/isi/  Product availability may vary by country.

Attend our #EuroPCR 2026 #ShockwaveIVL symposium to spark new ideas for modifying difficult calcium. ​ Dr @JuradoRomanAl and Dr @DrSaritaRao2 will lead a discussion with Prof @jcspratt, Dr @SBasavarajaiah, Dr @KambisMashayek1 and Dr @BeatrizVaqueri3 around #ShockwaveC2Aero, the latest Shockwave IVL data, and a recorded case from Prof @EmanueleBarba13 of Sant’Andrea University Hospital. ​ Learn more and mark your calendars for this 21 May event today: shockwavemedical.com/europcr-2026/?… US Rx only. Safety Information: shockwavemedical.com/isi/?utm_sourc… Product availability may vary by country.

We’re back at #RÖKO2026! 👋 Join us for dynamic conversations around #ShockwaveIVL, from real‑world applications and BTK case discussions to fresh insights straight from interventional practice. Most of all, we’re excited to exchange ideas on advancing the treatment of calcified lesions. See you soon in Leipzig at Booth D44! US Rx only. Safety Info: shockwavemedical.com/isi/ Product availability may vary by country.

A 15‑year cohort analysis of 21,132 ANOCA patients shows that individuals with angina, but no obstructive coronary artery disease, still face meaningful long-term cardiovascular risk when compared to matched individuals without obstructive disease: ➡️ Similar rates of myocardial infarction over 15 years ➡️ Slightly higher risk of ischemic stroke ➡️ Lower overall mortality vs. the general population ➡️ Outcomes strongly influenced by age and sex These findings highlight the importance of accurate diagnosis and tailored management for the #ANOCA population, who often continue to experience symptoms despite non‑obstructive coronaries. For International Physicians: With #ShockwaveReducer, we remain committed to advancing clinical evidence and supporting physicians caring for patients with this condition. 📖 Read the full article in @JACCJournals: jacc.org/doi/10.1016/j.…  🔗 Learn more about Shockwave Reducer: shockwavemedical.com/reducer?utm_so…  @KrisWarnakula @MMadsen_OPV @MaBMortensen @Hnriks @MichaelMaeng1 Safety Info: shockwavemedical.com/isi/​ CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

Want to simplify your approach to coronary calcium? Be sure to attend one of our five CALC Training Village sessions at this year’s #EuroPCR. Dr @GLGasparini, Prof @sinning_jan, Dr @PaoCanova, Dr Jan-Peter van Kuijk, Dr @simonjwilson1, Prof @jcspratt and Dr @DrSaritaRao2 will walk you through the straightforward CALC checklist and help you better understand when to deploy #ShockwaveIVL. Learn more: #village" target="_blank" rel="nofollow noopener">shockwavemedical.com/europcr-2026/?… ​ US Rx only. Safety Information: shockwavemedical.com/isi/ Product availability may vary by country.

#ShockwaveC2Aero is our most deliverable #CoronaryIVL catheter yet, and our #EuroPCR 2026 #ShockwaveIVL symposium cracks into all its Aero-volutionary capabilities!​ Watch moderator Dr @JuradoRomanAl's sneak preview of our symposium, which will feature a recorded live case from Prof @EmanueleBarba13 of Sant’Andrea University Hospital.​ Learn more and mark your calendars for this can't-miss 21 May event: shockwavemedical.com/europcr-2026/?… ​ US Rx only. Safety Information: shockwavemedical.com/isi/?utm_sourc… Product availability may vary by country.

Malaga is where DREAM meets #ShockwaveIVL. On May 16–17, DREAM Vascular puts the focus on diabetic foot care and complex peripheral disease. We’re proud to contribute to important discussions on managing calcified BTK disease and complex CLTI patients. Join this multidisciplinary course bringing together healthcare professionals dedicated to advancing the future of peripheral intervention. We hope to see you there! Dr. Marc Sirvent, Dr. Marta Lobato (@marlobat) US Rx only. Safety Info: shockwavemedical.com/isi/ ​ Product availability may vary by country.

Coverage matters. For patients with severe peripheral artery disease, including the 2 million people in the U.S. living with chronic limb threatening ischemia (CLTI), access to the right therapy can help change the course of their disease. Shockwave #PeripheralIVL is now included in Cigna Healthcare’s Peripheral Vascular Intervention policy, expanding access to medically necessary care for more than 16 million covered lives across the U.S. Coverage decisions like this can be meaningful steps toward broader access to evidence-based care. We’re proud of the teams working every day to expand access for the patients who need it most. Learn more about #ShockwaveIVL for Peripheral Artery Disease on our website: shockwavemedical.com/disease-states…  US Rx only. Safety Info: shockwavemedical.com/isi/ ​ Product availability may vary by country.

For International Physicians: Learn how #ShockwaveReducer is helping relieve pain and restore hope for angina patients by attending our #EuroPCR 2026 symposium. ​ Drs Rasha Al-Lamee (@rallamee) and Tommaso Gori (@tommasoggori) will moderate a fast-flowing discussion between Drs Ranil de Silva (@ranildesilva2), Mariusz Tomaniak (@MTomaniak), Oriol Rodriguez (@oriolrodriguez5) and Mike Foley (@MikeFoley89). Mark your calendars for Wednesday, 20 May at 13:40 and head to our website to learn more: #sponsored-sessions" target="_blank" rel="nofollow noopener">shockwavemedical.com/europcr-2026/?… ​ Safety Info: shockwavemedical.com/isi/ CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

We’re proud to celebrate the first office-based lab (OBL) case in Minnesota using #ShockwaveIVL! Congratulations to Dr. Nick Frank and the team at @RAYUSradiology for leading this milestone and expanding patient access to IVL in the outpatient setting. Many more to come! Learn more: shockwavemedical.com/office-based-l…  US Rx only. Safety Info: shockwavemedical.com/isi/ ​ Product availability may vary by country.

See Calcium, Think CALC! CALC, which stands for Calcium, Area, Length and Complexity, is a tool to help you determine the most appropriate calcium modification device for treatment of calcific coronary artery disease. Learn more about CALC at our #EuroPCR Training Village: shockwavemedical.com/europcr-2026/?…  US Rx only. Safety Info: shockwavemedical.com/isi/  Product availability may vary by country.

For International Physicians: 🔍 New Case Report Alert | #ShockwaveReducer A newly published case report in the European Heart Journal highlights how coronary sinus (CS) pressure modulation may improve symptoms in patients with microvascular angina- even when dysfunction is most pronounced in the right coronary artery (RCA), a territory not directly drained by the CS. In a 64-year-old patient with CCS class III angina and severe microvascular dysfunction, temporary CS occlusion resulted in a 40% reduction in IMR and a 75% increase in CFR in the RCA. Four weeks after implantation of the #ShockwaveReducer, the patient improved from CCS class III to class II. 🔗 Read the full case report:  academic.oup.com/eurheartj/arti…  🔗 Learn more about Shockwave Reducer:  shockwavemedical.com/reducer?utm_so…  @ChrisBrinkm Safety Info: shockwavemedical.com/isi/​ CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

Join us at #EuroPCR 2026 to see how our innovative technology is Proven to Deliver life-changing solutions for patients across the globe. ​ We have many exciting #ShockwaveIVL and #ShockwaveReducer sessions and activities planned, including symposiums, training villages, new clinical evidence and how to get cracking with the new #ShockwaveC2Aero. ​ Check them out today: shockwavemedical.com/europcr-2026/?…  IVL US Rx only. Reducer Investigational Use Only (US & CAN).​ Safety Information:  shockwavemedical.com/isi/  Product availability may vary by country.

Grateful for the exchange, the expertise, and the shared focus on calcium at the #CalciumLab Spring Edition in Verona. This spring, interventional radiologists, vascular surgeons, and angiologists together around one clear goal: deepening the understanding of peripheral calcium and how to approach it with confidence. Through hands-on sessions and case-based discussions, participants explored the Shockwave #PeripheralIVL portfolio and took a deeper dive into Shockwave IVL’s unique mechanism of action, translating science into meaningful clinical strategy. And the conversation doesn’t stop here. Calcium remains a challenge worth cracking, and the journey continues with the next edition. Learn more about #ShockwaveIVL for PAD: shockwavemedical.com/en-eu/disease-… Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: shockwavemedical.com/isi/ ​ Product availability may vary by country.

Kudos to Dr @hoole_stephen, Dr Patrick Heck, and the team at @RoyalPapworth Hospital in Cambridge for their participation in the COSIRA‑II study, joining the growing number of #COSIRAII enrolling sites and completing their first randomized patient for the COSIRA‑II trial in the UK! Learn more about the COSIRA‑II trial and participating sites: shockwavemedical.com/en-eu//clinica… Safety Info: shockwavemedical.com/isi/​ CAUTION: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada.

The first prospective, all-female, all-comers #EMPOWERCAD study demonstrated that a #ShockwaveIVL-first approach is a safe and effective treatment for female patients with calcified CAD.​ Learn more about this groundbreaking study and watch the full synopsis: #empower-video" target="_blank" rel="nofollow noopener">shockwavemedical.com/clinical-evide… US Rx only. Safety Info: shockwavemedical.com/isi/ ​ Product availability may vary by country.

The latest edition of Shockday in Verona was truly inspiring. Over the past couple of days, Verona set the stage for a dedicated Calcium Roundtable focused on advancing calcium treatment strategies. This year’s agenda took a deep dive into all things #ShockwaveIVL, complemented by live cases that helped translate clinical insights directly into practice. Thank you to Prof. Barbato (Ospedale Sant’Andrea, Rome) and Prof. Ribichini for sharing their valuable expertise, and to everyone who took part in this valuable discussion. Presenting physicians are paid consultants of Shockwave Medical. US Rx only. Safety Info: shockwavemedical.com/isi/ ​ Product availability may vary by country.